HS N-sulfation and iduronic acids play an important role in the infection of Respiratory Syncytial Virus in vitro

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 14, 2013, Pages 1864-1868

  Dong, L Q ^a   Wang, X Q ^a   Guo, Y N ^a   Wu, J ^a   Li, S ^a   Yu, P ^a   Wang, Z ^a  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

Heparan sulfate; Iduronic acids units; Infectio; N sulfation; Respiratory syncytial virus

Indexed keywords

HEPARIN LYASE; IDURONIC ACID; LOW MOLECULAR WEIGHT HEPARIN; BETA GLUCURONIDASE; HEPARANASE; HYDROGEN SULFIDE;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION SENSITIVITY; MAMMAL CELL; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SULFATION; VIROGENESIS; VIRUS INFECTIVITY; VIRUS INHIBITION; WESTERN BLOTTING; CELL LINE; CHEMISTRY; HELA CELL; METABOLISM;

BLOTTING, WESTERN; CELL LINE; FLOW CYTOMETRY; GLUCURONIDASE; HELA CELLS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYDROGEN SULFIDE; IDURONIC ACID; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84884181613     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. SUNEE T, PETER LC, MARK EP. Respiratory Syncytial Virus with the Fusion protein as Its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 2002; 294: 296-304.
2. KIMMAN TG, WESTENBRINK F. Immunity to human and bovine respiratory syncytial virus. Arch. Virol 1990; 112: 1-25.
3. CRIM RL, AUDET SA, FELDMAN SA, MOSTOWSKI HS, BEELER JA. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. J Virol 2007; 181: 261-271.
4. TECHAARPORNKUL S, COLLINS PL, PEEPLES ME. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 2002; 294: 296-304.
5. HALLAK LK, COLLINS PL, KNUDSON W, PEEPLES ME. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 2000; 271: 264- 275.
6. GUO Y, WANG Z, DONG L, WU J, ZHAI S, LIU D. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection. Nephrology 2008; 13: 545-553.
7. LIU XM, WANG Z, GUO Y. Respiratory syncytial virus nephropathy in rats. Kidney Int 2007; 71: 388-396.
8. FELDMAN SA, AUDET S, BEELER JA. The fusion glycoprotein of human respiratory syncytial vi rus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol 2000; 74: 6442-6447.
9. CAUTIVO KM, BUENO SM, CORTES CM, WOZNIAK A, RIEDEL CA, KALERGIS AM. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection. J Immunol 2010; 12: 7633-7645.
10. YAMADA T, KAWASAKI T. Microbial synthesis of hyaluronan and chitin:new approaches. J Biosci Bioeng 2005; 99: 521-528.
11. BALDASSARRI L, BERTUCCINI L, CRETI R, FILIPPINI P, AMMENDOLIA MG, KOCH S, HUEBNER J, OREFICI G. Glycosaminoglycans mediate invasion and survival of Enterococcus faecalis into macrophages. J Infect Dis 2005; 191: 1253-1262.
12. BOUSARGHIN L, HUBERT P, FRANZEN E, JACOBS N, BONIVER J, DELVENNE P. Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J Gen Virol 2005; 86: 1297- 1305.
13. RUE CA, RYAN P. Characterization of pseudorabies virus glycoprotein C attachment to heparan sulfate proteoglycans. J Gen Virol 2002; 83: 301- 309.
14. JONES KS, PETROW-SADOWSKI C, BERTOLETTE DC, HUANG Y, RUSCETTI FW. Heparan sulfate proteoglycans mediate attachment and entry of human Tcell leukemia virus type 1 virions into CD4+ T cells. J Virol 2005; 79: 12692-12702.
15. FELDMAN SA, CRIM RL, AUDET SA, BEELER JA. Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex. Arch Virol 2001; 146: 2369-2383.
16. SHIELDS B, MILLS J, GHILDYAL R, GOOLEY P, MEANGER J. Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells. ArchVirol 2003; 148: 1987-2003.
17. PRESTO J, THUVESON M, CARLSSON P, BUSSE M, WILÉN M, ERIKSSON I, KUSCHE-GULLBERG M, KJELLÉN L. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc Natl Acad Sci USA 2008; 105: 4751-4756.
18. CARLSSON P, PRESTO J, SPILLMANN D, LINDAHL U, KJELLÉN L. Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. J Biol Chem 2008; 283: 20008-20014.
19. ESKO JD, SELLECK SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-471.
20. HASHIMURA Y, NOZU K, KANEGANE H, MIYAWAKI T, HAYAKAWA A, YOSHIKAWA N, NAKANISHI K, TAKEMOTO M, IIJIMA K, MATSUO M. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Nephrol 2009; 24: 1181-1186.